CIDRAP newsletters options
With antimicrobial use in livestock expected to double in 30 years, the FAO says nations' AMR capacities need bolstering.
Study estimates 12,000 excess deaths 2 weeks after ICUs reach 75% occupancy.
"As a clinician deep in the clinical trenches, I am really grateful we have clarity," says one ACIP expert.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
New data from the European Centre for Diseases Prevention and Control (ECDC) show a dramatic drop in community antibiotic use across Europe during the first year of the COVID-19 pandemic.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Kansas, Louisiana, Maine, and Rhode Island become the latest to expand eligibility for COVID-19 boosters.
Data suggest that interest in antibiotic R&D and in curbing environmental impact is growing.
Austria, Germany, and the Netherlands all report record high daily cases.
COVID-19 interventions might worsen loneliness, financial stress, and other mental health issues.
The US Centers for Disease Control and Prevention (CDC) published a new comprehensive survey of vaccine uptake in healthcare workers (HCWs), showing that after initial enthusiasm, vaccine uptake stalled at 70% by Sep 15, 2021. Results of the survey are published in the American Journal of Infection Control.
Data show that people taking immunosuppressive drugs, including cancer patients, are not at higher risk.
For the 4th week in a row, the rate of new global COVID-19 cases rose, led by surges in Europe.
By the end of today 2.6 million young American children will have gotten their first shot.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
A coalition of organizations from academia, healthcare, and the pharmaceutical industry sent a letter today to G7 governments calling for greater engagement in tackling antimicrobial resistance (AMR) and boosting the pipeline for new antibiotics.
Of the patients taking fluoxetine (Prozac), 9.8% died, versus 13.3% of control patients, a 28% reduction.
Pfizer has applied for emergency use authorization from the FDA for Paxlovid, its COVID-19 drug.
More than 95% of the state's available inpatient hospital beds are filled with patients.
An automated text messaging system for adult COVID-19 outpatients developed at Penn Medicine saved two lives a week during the first US pandemic surge, and users were 68% less likely than controls to die, finds a study today in the Annals of Internal Medicine.
